The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function. The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users. The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biomaterials market size grew from $104.36 billion in 2022 to $119.95 billion in 2023 at a compound annual growth rate (CAGR) of 14.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biomaterials market size is expected to grow to $219.79 billion in 2027 at a CAGR of 16.3%. The rising incidence of cardiovascular diseases is driving the growth of the biomaterials market. Cardiovascular disorders are caused by high blood pressure, smoking, high cholesterol, inactivity, and other factors. The increase in the prevalence of cardiovascular disorders is mainly due to noncontagious diseases like diabetes, chronic respiratory illness, and heart attacks due to hypertension. Biomaterials such as heart valves, cardiopulmonary bypass system, stents, vascular grafts, complete artificial heart, and pacemakers are used as a healing mechanism for damaged and diseased heart tissue. For instance, in October 2022, according to a report shared by The Centers for Disease Control and Prevention, a US-based national public health agency, the main cause of death in the United States for men, women, and members of the majority of racial and ethnic groups is heart disease. In the United States, heart disease caused approximately 697,000 fatalities in 2020, or one death out of every five. In the United States, a cardiovascular disease death occurs every 34 seconds. Therefore, the rising incidence of cardiovascular diseases will increase the demand for biomaterials. The strategic partnership is a key trend gaining popularity in the biomaterials market. Key companies are focusing on partnerships to develop new implants and combination devices based on biomaterials by leveraging each other’s expertise, technology, and resources. These partnerships are also focused on enhancing the adoption of biomaterials. Such partnerships enable companies to gain a competitive edge in the market and increase revenue. For instance, in December 2020, DuPont, a US-based producer of biomaterials, partnered with a Finland-based global chemicals company, Kemira Oyj, for development and commercialization of new breakthrough biomaterials. In the partnership, Kemira's role would be to jointly develop and market a variety of novel biobased and biodegradable goods across Kemira's major product lines. As per the conditions of the partnership, Kemira will have access to the engineered polysaccharide platform, a novel and distinctive biomaterial technology from DuPont. Through this partnership, the two parties will soon be able to sell a variety of novel, biobased, and biodegradable products in their respective core industries. In January 2021, Evonik Industries AG, a German specialty chemicals company acquired the LACTEL business of biodegradable polymers from DURECT Corporation for $15 million. With this acquisition, Evonik aims to expand in fast-growing markets such as biomaterials for tissue engineering, advanced drug delivery, and the 3D printing of implantable medical devices. DURECT Corporation is a US-based specialty pharmaceutical company. Major players in the biomaterials market are Carpenter Technology Corporation, Corbion NV, Evonik Industries, Royal DSM, Berkeley Advanced Biomaterials, BASF SE, Zimmer Biomet, Johnson and Johnson, Invibio, Medtronic, Organogenesis Holdings Inc., Stryker, Wright Medical Group NV, 3M Healthcare, AdvanSource Biomaterials Corporation, Baxter, Covestro, Cam Bioceramics BV, Celanese Corporation, CoorsTek Inc., CeramTec, Victrex plc and Collagen Matrix Inc., North America was the largest region in the biomaterials market in 2022. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biomaterials market is segmented - 1) By Type: Metallic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, Ceramics 2) By Application: Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System 3) By End Use: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users

An implantable biomaterial is a natural or synthetic material that is used in medical applications to support, enhance, or replace damaged tissue or a biological structure. The main materials in the implantable biomaterials are the materials such as metallic, ceramic, polymers, and natural. Metallic implants in implantable biomaterials refer to the component that is widely selected for orthopedic prosthesis over polymeric biomaterials and traditional ceramic materials and is used for the enhancement of biological activities. The various applications include dental, cardiovascular, ophthalmology, orthopedic, and others. These are used in hospitals, ambulatory surgical centres, and specialty clinics. The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with a implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global implantable biomaterials market grew from $113.64 billion in 2022 to $127.97 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The implantable biomaterials market is expected to grow from $198.4 billion in 2027 at a CAGR of 11.6%. The allocation of funds by government organizations in the development of new biomaterials [SR1] contributed to the implantable biomaterials market growth. For instance, Drexel University granted USD 200,000 to the National Science Foundation for research on biomaterial-mediated control over macrophage behavior that affects biomaterial vascularization. The support from government organizations in the development of new biomaterials will drive the implantable biomaterials market. Limitations of biomaterial-based products are a major challenge for the implantable biomaterials market. For instance, metal biomaterials can corrode due to chemical reactions within the body such as enzymes and acids or it can also cause some metal ion toxicity in the body. Polymer biomaterial implants have intensive interaction with the body and can lead to wear and tear and can absorb the important nutrients and water from the blood. Some biomaterial implants can also minimize bone ingrowth or sometimes, implants can loosen over time and become dislodged. These reactions that biomaterials have with the body restrain their use thereby negatively impacting the implantable biomaterials market's growth. Major companies in the implantable biomaterials market are implementing 3D printing of biomaterials in manufacturing. For instance, Evonik is producing 3D printable biomaterials for medical technology that are used for manufacturing medical implants with permanent body contact and temporary body contact line of bioresorbable filaments and powders. Implants with permanent body contact are based on Vestakeep Peek, and with the temporary body, contact is based on Resume. In April 2022, Integer Holdings Corporation, a US-based medical device company, acquired Connemara Biomedical Holdings Teoranta for an undisclosed amount. The acquisition would bring implantable biomaterial technology to Integer’s control and help its growth. Connemara Biomedical Holdings Teoranta is a Ireland-based manufacturer of biomaterials for cardiovascular implants. Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation. North America was the largest region in the implantable biomaterials market in 2022. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the global implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the implantable biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global implantable biomaterials market is segmented - 1) By Material: Metallic, Ceramic, Polymers, Natural 2) By Application: Dental, Cardiovascular, Ophthalmology, Orthopedic, Other Applications 3) By End-user: Hospitals, Ambulatory Surgical Centers, Specialty Clinics

Surgical equipments are tools or devices that perform such functions as cutting, dissecting, grasping, holding, retracting, or suturing. Most surgical instruments are made from stainless steel. The main types of surgical equipment are surgical sutures and staples, handheld surgical devices and equipment, electrosurgical devices, and equipment. The surgical sutures, also known as stitches, are sterile surgical threads used to repair cuts. They are used to close incisions in surgery. Staples is a town used as a centre for the sale or exportation of commodities in bulk. The type of expenditure is public or private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The surgical equipment market research report is one of a series of new reports from The Business Research Company that provides surgical equipment market statistics, including surgical equipment industry global market size, regional shares, competitors with a surgical equipment market share, detailed surgical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the surgical equipment industry. This surgical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global surgical equipment market grew from $27.05 billion in 2022 to $29.04 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical equipment market is expected to grow to $36.49 billion in 2027 at a CAGR of 5.9%. The growing demand for minimally invasive surgery (MIS) will increase the demand for advanced surgical equipment. An MIS refers to any surgical procedure that requires minimal incisions as opposed to traditional or open surgery used for the same purpose. Preference for MIS procedures increased due to their multiple advantages such as short healing and recovery time, minimal scarring, cost-effectiveness, minimal trauma and pain, and decreased risk of infections and complications. Medical technology innovations led to the development of advanced surgical equipment such as Da Vinci surgical systems, C-arm devices, and electrosurgical and power-assisted surgical equipment. These devices which enable MIS will drive the surgical equipment market during the forecast period. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, making it harder for companies in the surgical equipment market to raise funds for developing new devices thereby affecting the market growth. Surgical equipment manufacturers are offering next-generation ultrasonic surgical devices to simplify complex surgical procedures. Modern ultrasonic surgical devices are multifunctional instruments capable of performing tissue plane dissection, coagulation, and transection during laparoscopic or open surgical procedures. Next-generation ultrasonic devices feature adaptive tissue technology. In this technology ultrasonic algorithm actively monitors the condition of the tissue within the jaws of the device and allows the system to intelligently sense and respond to changes in patient tissue conditions. The system modulates energy delivery based on tissue thickness and tissue type to optimize vessel sealing and provide for secure and reliable large vessel sealing. Ethicon’s Harmonic devices feature adaptive tissue technology Major companies in the surgical equipment market include Johnson & Johnson (J&J), Stryker Corporation, Intuitive Surgical, B. Braun Melsungen AG, and Getinge Group. North America was the largest region in the global surgical equipment market in 2022. Western Europe was the second-largest region in the global surgical equipment market. The regions covered in the surgical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The surgical equipment market consists of sales of instruments such as forceps & spatulas, retractors, dilators, graspers, auxiliary instruments, and cutter instruments that are used for surgeries. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical equipment market is segmented - 1) By Type: Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Surgical sealants and adhesives are materials used to repair injured tissues and prevent air and fluid leakages during or after surgeries. These are used for minimising blood losses, replacing staples and sutures for better closure, and strengthening wound areas without limiting tissue movement. The surgical sealants and adhesives market covered in this report is segmented by product into biological sealants, synthetic sealants, and semi-synthetic sealants. The biological sealants are made up of biological material that is used to repair injured tissues and prevent air and fluid leakages during or after the surgeries. These are used for various indications such as tissue sealing, tissue engineering, and hemostasis and are used by end-uses such as hospitals, clinics, and others. The surgical sealants and adhesives market research report is one of a series of new reports from The Business Research Company that provides surgical sealants and adhesives market statistics, including surgical sealants and adhesives industry global market size, regional shares, competitors with a surgical sealants and adhesives market share, detailed surgical sealants and adhesives market segments, market trends and opportunities, and any further data you may need to thrive in the surgical sealants and adhesives industry. This surgical sealants and adhesives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global surgical sealants and adhesives market grew from $2.39 billion in 2022 to $2.63 billion in 2023 at a compound annual growth rate (CAGR) of 9.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical sealants and adhesives market is expected to grow from $3.38 billion in 2027 at a CAGR of 6.5%. The rising number of surgical procedures is predicted to contribute to the growth of the surgical sealants and adhesives market. In recent years, the continuous surge in surgical procedures is registered attributing to the growing prevalence of obesity and other lifestyle diseases, increasing incidence of spinal and sports-related injuries, and rising geriatric population. The old-age population is more prone to chronic, heart, and other diseases, thereby undergoing surgical procedures. According to the World Health Organization, the number of people over the age of 65 is projected to increase from 1 billion in 2020 to 2.1 billion by 2050, globally. The advances in surgical procedures are anticipated to hinder the growth of the surgical sealants and adhesives market. Minimal invasive surgeries are replacing conventional surgical procedures, eliminating complications including bleeding and air leakage and therefore, limiting the use of any surgical sealants and adhesives. According to the American Society of Plastic Surgeons (ASPS), approximately 18 million people undergoing surgical and minimally invasive cosmetic procedures in the USA. Hence, the growing number of minimally invasive surgeries and other substitutes for conventional surgical processes is predicted to impact the growth of the market over the forthcoming years. Several companies operating in the market are focusing on product portfolio expansion into untapped geographies. For instance, in January 2020, Terumo Corporation announced the launch of AQUABRID, a new surgical sealant in the EMEA market. AQUABRID is specially developed for aortic procedures to stop bleeding during and post surgeries. The company earlier introduced this product in Japan under the brand name Hydrofit and is under the process of registration in Eastern Europe, the Middle East, and Africa. In December 2021, Becton, Dickinson and Company, a US-based medical technology company, acquired Tissuemed, Ltd for an undisclosed amount. The acquisition would complete BD’s core portfolio and enable BD to further strengthen the surgical sealants portfolio. Tissuemed is a England-based surgical sealants manufacturer. Major players in the surgical sealants and adhesives market are Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Sanofi, Ocular Therapeutix, Inc., and Sealantis Ltd. North America was the largest region in the surgical sealants and adhesives market in 2022. Western Europe was the second largest region in the global surgical sealants and adhesives market report. The regions covered in the global surgical sealants and adhesives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical sealants and adhesives report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The patient handling equipment market consists of sales of fibrin sealants, collagen based adhesives, gelatin based adhesives, cyanoacrylates, polymeric hydrogels, and urethane based adhesives. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical sealants and adhesives market is segmented - 1) By Product: Biological Sealants, Synthetic Sealants, Semi-Synthetic Sealants 2) By Indication: Tissue Sealing, Tissue Engineering, Hemostasis 3) By End Use: Hospitals, Clinics, Other End Uses

Surgical arms are a vital component used in the field of surgery, especially for performing minimally invasive procedures. These are robotic arms that are controlled by surgions. The surgical imaging arms market covered in this report is segmented by product type into G-arm surgical imaging devices, C-arm surgical imaging devices, O-arm surgical imaging devices; by technology into image intensifier C-arms, flat panel detector C-arms; by application into orthopaedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, other applications; by end-user into hospitals and ambulatory surgical centers, academic research institutes. The surgical imaging arm market research report is one of a series of new reports from The Business Research Company that provides surgical imaging arm market statistics, including surgical imaging arm industry global market size, regional shares, competitors with a surgical imaging arm market share, detailed surgical imaging arm market segments, market trends and opportunities, and any further data you may need to thrive in the surgical imaging arm industry. This surgical imaging arm market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global surgical imaging arms market size grew from $1.23 billion in 2022 to $1.32 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical imaging arms market size is expected to grow to $1.75 billion in 2027 at a CAGR of 7.3%. High demand for mini C-arms devices is expected to boost market growth during the forecast period. Globally, companies are engaged in the development and manufacturing of novel equipment that assists surgeons in carrying out surgical procedures smoothly and efficiently. The rising demand for mini C-arms devices can be attributed to features, such as their miniaturized size, easy adaptability in the operation theatre, and lower price than other types of C-arms. For instance,in July 2022, Fujifilm, a Germany-based company that produces and distributes photographic and imaging products and services, launched FDR CROSS. FDR CROSS is a versatile, hybrid C-arm and portable x-ray machine. The technology offers a more effective and streamlined workflow by capturing fluoroscopic and radiographic pictures on a single platform. Thus, the rising demand for mini C-arms combined with their easy-to-use features is expected to drive market growth. The high cost of surgical imaging arms is anticipated to hamper market growth during the forecast period. Recently, the prices of surgical arms are increasing owing to constant research and development to introduce new features in the devices. The price of C-arm imaging devices ranges from $25,000 to greater than $70,000. The advanced C-arms such as Siemens Cios Fusion of Siemens Healthcare and OEC 9900 of GE Healthcare range between $1,50,000 and $2,00,000. The average refurbished mini C-arm price ranges between $19,000 and $50,000. Health care settings face challenges with the high costs of these devices that are predicted to hinder market growth. Integration of technology for real-time visualization during surgeries is gaining significant popularity in the surgical imaging arms market. With the increasing number of patients requiring surgeries, the scope and complexity of surgical interventions such as image-guided minimally invasive surgery continue to surge. In January 2020, Philips announced major innovations in its Zenition mobile C-arm platform. With the new user interface, the clinician will be able to operate C-arm inside the sterile field, reducing the communication burden with the operator and making it more intuitive to control the system. Moreover, the platform is extended to integrate intravascular ultrasound (IVUS) for peripheral vascular procedures for improving workflow and streamlining the operating room. In August 2021, TBS Medical Equipment Services, a US-based company that provides medical facilities and services, acquired Omni Imaging Service (Omni) for an undisclosed amount. Through this acquisition, TBS Medical Equipment Services bolstered its foundation and boosted its capacity to deliver high-quality services across the nation. Omni Imaging Service (Omni) is a US-based OEC C-Arm parts and services company. Major players in the surgical imaging arms market are GE Healthcare, Hologic Inc., ATON GmbH, Whale Imaging Inc., Siemens Healthcare, Shimadzu Corp., Canon Medical Systems Corporation, Medtronic plc, Ziehm Imaging, and Philips Healthcare. North America was the largest region in the surgical imaging arms market in 2022. Asia-Pacific was the second largest region in the surgical imaging arms market. The regions covered in the surgical imaging arms market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the surgical imaging arms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The surgical imaging arms market consists of sales of bronchoscopes, heolders & positioners, and retractor systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical imaging arms market is segmented - 1) By Product Type: G-Arm Surgical Imaging Devices, C-Arm Surgical Imaging Devices, O-Arm Surgical Imaging Devices 2) By Technology: Image Intensifier C-Arms, Flat Panel Detector C-Arms 3) By Application: Orthopaedic And Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries, Other Applications 4) By End-User: Hospitals And Ambulatory Surgical Centers, Academic Research Institutes

Hand-held surgical instruments are usually built of premium stainless steel and come in a wide range of sizes, styles, and shapes appropriate for various surgical procedures. Hand-held surgical instruments are used in the surgical procedures and operated on while being held in hand. A wide variety of hand-held surgical instruments are used in numerous surgical operations, including scalpels, forceps, scissors, and retractors. The main product types of hand-held surgical instruments are forceps, retractors, dilators, graspers, scalpels, and others. Forceps are used for securely grabbing, pulling, or holding items, especially during delicate operations. A forceps is a two-bladed tool with a handle that can be used for various tasks, including managing sterile dressings, squeezing or gripping tissues, and others. Neurosurgery, cardiovascular, orthopedic, plastic and reconstructive surgery, obstetrics and gynecology are the applications of hand-held surgical instruments. These instruments are used by hospitals, clinics, and ambulatory surgical centers. The hand-held surgical instruments market research report is one of a series of new reports from The Business Research Company that provides hand-held surgical instruments market statistics, including hand-held surgical instruments industry global market size, regional shares, competitors with a hand-held surgical instruments market share, detailed hand-held surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the hand-held surgical instruments industry. This hand-held surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global hand-held surgical instruments market size grew from $5.99 billion in 2022 to $6.48 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hand-held surgical instruments market size is expected to grow to $8.63 billion in 2027 at a CAGR of 7.4%. An increase in the geriatric population is driving the hand-held surgical instruments market. The geriatric population consists of adults 65 years of age and older. People at this age are more prone to fall ill and catch a severe disease that needs proper treatment and surgical intervention. Surgical instruments are used in surgeries and carrying out treatment for various diseases. For instance, according to a report by United Nations on World Population Ageing 2020, a US-based intergovernmental organization, the world population aging in 2020 was about 727 million people aged over 65 years and expected to reach 1.5 billion in 2050. Throughout the world, there is an increased population of over-aged 65-year-olds, which stood at 9.3% in 2020 and is expected to reach 16.0% by 2050. Therefore, the increasing geriatric population will propel the hand-held surgical instruments market. Technological advancement is a key trend gaining popularity in the hand-held surgical instruments market. Major players in the hand-held surgical instruments market are adopting smart surgical instruments to treat various diseases. Smart surgical instruments are user-friendly, advanced tools that save time and money. For instance, in November 2021, OrthAlign, a US-based medical equipment manufacturer, introduced a new, hand-held smart surgical instrument called Lantern for full and partial knee replacements. The solution offers streamlined workflows to reduce operating room wait times and support numerous operating rooms at once without requiring the investment in hardware or pre-operative imaging required by various computer-assisted surgical systems. In October 2020, Katena Products Inc., a surgical equipment provider that includes cannulas, forceps, needle holders, phaco choppers, scissors, spatulas, and many more, acquired Micro Select for an undisclosed amount. With this acquisition, Katena will expand its production of fine ophthalmic tools and manufacturing facilities. Micro Select Instruments Inc. is full-service surgical instrument manufacturing and repair company. Major players in the hand-held surgical instruments market are Johnson & Johnson, B Braun Melsungen AG, Medtronic, Zimmer Biomet Holdings, KLS MARTIN GROUP, Integra LifeSciences Corporation, Smith & Nephew, Aspen Surgical, CooperSurgical Inc., Thompson Surgical Instruments Inc., Becton Dickinson and Company, Swann-Morton Ltd., Peters Surgical, Huaiyin Medical Instruments CoLtd and CONMED Corporation. North America was the largest region in the hand-held surgical instruments market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hand-held surgical instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hand-held surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The hand-held surgical instruments market consists of sales of cannulas, dermatome, and trocars. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hand held surgical instruments market is segmented - 1) By Product: Forceps, Retractors, Dilators, Graspers, Scalpels, Other Products 2) By Application: Neurosurgery, Cardiovascular, Orthopedic, Plastic And Reconstructive Surgery, Obstetrics And Gynecology, Other Applications 3) By End User: Clinics, Ambulatory Surgical Centers, Other End Users

AI-based surgical robots are surgical robots powered by artificial intelligence which are well-known in the medical field and are frequently used. They are computer-manipulated devices that allow surgeons to focus on the complex aspects of surgery. The main product in AI based surgical robotics markets are services, instrument & accessories. Services include such as capture and analyzing patient information for initial diagnosis and assisting surgeons with complex surgeries. The various applications include orthopedics, neurology, urology, gynecology, and others. These are used by hospitals and ambulatory surgical centers. The AI-based surgical robots market research report is one of a series of new reports from The Business Research Company that provides AI-based surgical robots market statistics, including AI-based surgical robots industry global market size, regional shares, competitors with a AI-based surgical robots market share, detailed AI-based surgical robots market segments, market trends and opportunities, and any further data you may need to thrive in the AI-based surgical robots industry. This AI-based surgical robots market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global AI-based surgical robots market size grew from $4.73 billion in 2022 to $5.63 billion in 2023 at a compound annual growth rate (CAGR) of 19.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The AI-based surgical robots market size is expected to grow to $10.41 billion in 2027 at a CAGR of 16.6%. The increase in the adoption of technologically advanced robots by surgeons for various applications has contributed to the growth of the AI-based surgical robots market. Robots are automated machines that can perform pre-programmed tasks. With the advancement in technology AI technology is also being used to improve, the efficiency, accuracy, and performance of robots. AI-based surgical robots are used in various surgeries and specialties such as neurology, urology, ENT, thoracic surgery, colorectal surgery, and others. According to data published in the JAMA Network, a medical journal published by American Medical Association, open surgery for prostate cancer is being replaced by robotic surgeries as they offer fewer complications and better functional outcomes. Data states that up to 86% of procedures for prostate cancer in the US in 2020, performed by robots. Therefore, the Increasing adoption of technologically advanced robots by surgeons for various applications is driving the AI-based surgical robots market. The development of new products is a key trend gaining popularity in the AI-based surgical robots market. Major companies operating in the market are developing new products to strengthen their position in the market. For Instance, Suzhou KangDuo Robot Co., a China-based medical company, launched "KangDuo Surgical Robot-01 (KD SR 01)". The device completed a robot-assisted radical pyeloplasty. These surgeries performed by the KD SR 01 required less time and have demonstrated advantages over conventional methods such as laparoscopic surgery. In May 2020, Medtronic, a US-based medical device company, announced that it would acquire Digital Surgery for an undisclosed amount. With this acquisition, Digital Surgery would become a part of Medtronic’s minimally invasive therapies group. Through this deal, Medtronic would enable digital solutions with robotic platforms and would have a significant impact on enhancing patient access. Digital Surgery is a UK-based company that develops AI-powered surgical video and analytics platforms under the Touch Surgery brand name. Major players in the ai-based surgical robots market are Accuray Incorporated, Intuitive Surgical Inc., Medtronic plc, Medrobotics Corporation, Zimmer Biomet, Stereotaxis Inc., TransEnterix Inc., Stryker Corporation, Activ Surgical Inc., Titan Medical Inc., CMR Surgical Inc., Medtech Surgical, and Mazor Robotic. North America was the largest region in the AI based surgical robots market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in AI based surgical robots market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the AI based surgical robots market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The AI-based surgical robots market consists of sales of rehabilitation robots, laboratory robots, and robotic prosthetic. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global AI based surgical robots market is segmented - 1) By Product: Services, Instrument and Accessories 2) By Application: Orthopedics, Neurology, Urology, Gynecology, Other Applications 3) By End User: Hospitals, Ambulatory Surgical Centres

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices